Telegram
LinkedIn
Facebook
About Us
Bioequivalence Services
R&D Phase
Clinical & Bioanalytical Phase
CRO Selection & Qualification Auditing
Study Planning & Protocol
BE Study Monitoring
Medical Writing Phase
Pharmacokinetic Calculations & Statistical Analysis
Review of Final Reports
Regulatory Support
Failed BE study Analysis
Biostatistical Services
Training Services
Resources
News
New Event
Contact us
About Us
Bioequivalence Services
R&D Phase
Clinical & Bioanalytical Phase
CRO Selection & Qualification Auditing
Study Planning & Protocol
BE Study Monitoring
Medical Writing Phase
Pharmacokinetic Calculations & Statistical Analysis
Review of Final Reports
Regulatory Support
Failed BE study Analysis
Biostatistical Services
Training Services
Resources
News
New Event
Contact us
Resources
16848
wp-singular,page-template-default,page,page-id-16848,wp-theme-bridge,bridge-core-3.0.1,qodef-qi--no-touch,qi-addons-for-elementor-1.5.1,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-28.2,qode-theme-bridge | shared by wptry.org,qode_header_in_grid,wpb-js-composer js-comp-ver-6.7.0,vc_responsive,elementor-default,elementor-kit-6
Resources
Home
>
Resources
General Guidlines
FDA
EMA
EU
ICH
WHO
GCC
EDA
Name
Type
Format
Bioequivalence
Document
PDF
Name
Type
Format
Bioequivalence Studies
Document
PDF
Name
Type
Format
European Guidelines related to bioequivalence
External Link
URL
Molecule Name
Dosage Form
Strength
Abiraterone
Oral tablet
250 mg
Agomelatine
Tablet
25 mg
Alectinib
Hard capsule
150 mg
Aliskiren
Film-coated
150 mg and 300 mg
Apixaban
Film-coated tablet
2.5 and 5 mg
Asenapine
Sublingual tablets
5 mg, 10 mg